test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AMZNAmazon Com Inc
Recent Activity
Increased 78.92%
2.07%
$5.999M
32,193 shares@ $186.34 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 38.22%
1.77%
$5.103M
44,661 shares@ $114.27 avg price
ACLXArcellx Inc
Recent Activity
Increased 8.04%
1.59%
$4.605M
55,139 shares@ $83.52 avg price
XPOXpo Inc
Recent Activity
Increased 47.89%
1.4%
$4.051M
37,680 shares@ $107.52 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
Increased 321.64%
1.39%
$4.028M
89,508 shares@ $45.0 avg price
ARGXArgenx Se
Recent Activity
Increased 8.33%
1.34%
$3.878M
7,154 shares@ $542.08 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
Increased 9.66%
1.09%
$3.158M
139,544 shares@ $22.64 avg price
KROSKeros Therapeutics Inc
Recent Activity
Increased 32.9%
1.05%
$3.026M
52,107 shares@ $58.07 avg price
NUVLNuvalent Inc
Recent Activity
Increased 1.12%
1.03%
$2.969M
29,018 shares@ $102.3 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 1.44%
1.01%
$2.904M
73,762 shares@ $39.38 avg price